Two Rare Variants Explain Association with Acute Myocardial Infarction in an Extended Genomic Region Including the Apolipoprotein(A) Gene

Annals of Human Genetics

Volumn 77, Issue 1, 2013, Pages 47-55

  Koch, Werner ^a   Mueller, Jakob C ^b   Schrempf, Matthias ^a   Wolferstetter, Hannah ^a   Kirchhofer, Johannes ^a   Schömig, Albert ^a,c   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MAX PLANCK INSTITUTE FOR ORNITHOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Apolipoprotein(a); Coronary artery disease; Genetics; Haplotype; Myocardial infarction; Single nucleotide polymorphism

Indexed keywords

APOLIPOPROTEIN A; GENOMIC DNA;

ACUTE HEART INFARCTION; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS A; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84871540277     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/j.1469-1809.2012.00739.x     Document Type: Article

References (46)

1. Anuurad, E., Enkhmaa, B. & Berglund, L. (2010) Enigmatic role of lipoprotein(a) in cardiovascular disease. Clin Transl Sci 3, 327-332.
2. Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265.
3. Bennet, A., Di Angelantonio, E., Erqou, S., Eiriksdottir, G., Sigurdsson, G., Woodward, M., Rumley, A., Lowe, G. D. O., Danesh, J. & Gudnason, V. (2008) Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data. Arch Intern Med 168, 598-608.
4. Berglund, L. & Ramakrishnan, R. (2004) Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol 24, 2219-2226.
5. Byrne, C. D., Schwartz, K. & Lawn, R. M. (1995) Loss of a splice donor site at a 'skipped exon' in a gene homologous to apolipoprotein(a) leads to an mRNA encoding a protein consisting of a single kringle domain. Arterioscler Thromb Vasc Biol 15, 65-70.
6. Caplice, N. M., Mueske, C. S., Kleppe, L. S. & Simari, R. D. (1998) Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity. Circulation 98, 1051-1057.
7. Caplice, N. M., Panetta, C., Peterson, T. E., Kleppe, L. S., Mueske, C. S., Kostner, G. M., Broze, G. J. Jr. & Simari, R. D. (2001) Lipoprotein(a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood 98, 2980-2987.
8. Chalmers, J., MacMahon, S., Mancia, G., Whitworth, J., Beilin, L., Hansson, L., Neal, B., Rodgers, A., Ni Mhurchu, C. & Clark, T. (1999) 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens 21, 1009-1060.
9. Chasman, D. I., Shiffman, D., Zee, R. Y. L., Louie, J. Z., Luke, M. M., Rowland, C. M., Catanese, J. J., Buring, J. E., Devlin, J. J. & Ridker, P. M. (2009) Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy. Atherosclerosis 203, 371-376.
10. Clarke, R., Peden, J. F., Hopewell, J. C., Kyriakou, T., Goel, A., Heath, S. C., Parish, S., Barlera, S., Franzosi, M. G., Rust, S., Bennett, D., Silveira, A., Malarstig, A., Green, F. R., Lathrop, M., Gigante, B., Leander, K., De Faire, U., Seedorf, U., Hamsten, A., Collins, R., Watkins, H. & Farrall, M., for the PROCARDIS Consortium. (2009) Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 361, 2518-2528.
11. Danesh, J., Collins, R. & Peto, R. (2000) Lipoprotein(a) and coronary heart disease: meta-analysis of prospective studies. Circulation 102, 1082-1085.
12. De Kok, J. B., Wiegerinck, E. T. G., Giesendorf, B. A. J. & Swinkels, D. W. (2002) Rapid genotyping of single nucleotide polymorphisms using novel minor groove binding DNA oligonucleotides (MGB probes). Hum Mutat 19, 554-559.
13. Gaubatz, J. W., Heideman, C., Gotto, A. M. Jr., Morrisett, J. D. & Dahlen, G. H. (1983) Human plasma lipoprotein [a]: structural properties. J Biol Chem 258, 4582-4589.
14. Gaunt, T. R., Rodriguez, S., Zapata, C. & Day, I. N. M. (2006) MIDAS: software for analysis and visualisation of interallelic disequilibrium between multiallelic markers. BMC Bioinformatics 7, 227.
15. Grainger, D. J., Kirschenlohr, H. L., Metcalfe, J. C., Weissberg, P. L., Wade, D. P. & Lawn, R. M. (1993) Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 260, 1655-1658.
16. Grainger, D. J., Kemp, P. R., Liu, A. C., Lawn, R. M. & Metcalfe, J. C. (1994) Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice. Nature 370, 460-462.
17. Gründemann, D., Schechinger, B., Rappold, G. A. & Schömig, E. (1998) Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1, 349-351.
18. Gründemann, D. & Schömig, E. (2000) Gene structures of the human non-neuronal monoamine transporters EMT and OCT2. Hum Genet 106, 627-635.
19. Holmer, S. R., Hengstenberg, C., Kraft, H.-G., Mayer, B., Pöll, M., Kürzinger, S., Fischer, M., Löwel, H., Klein, G., Riegger, G. A. J. & Schunkert, H. (2003) Association of polymorphisms of the apolipoprotein(a) gene with lipoprotein(a) levels and myocardial infarction. Circulation 107, 696-701.
20. Kamstrup, P. R., Benn, M., Tybjærg-Hansen, A. & Nordestgaard, B. G. (2008) Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation 117, 176-184.
21. Kamstrup, P. R., Tybjærg-Hansen, A., Steffensen, R. & Nordestgaard, B. G. (2009) Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 301, 2331-2339.
22. Kutyavin, I. V., Afonina, I. A., Mills, A., Gorn, V. V., Lukhtanov, E. A., Belousov, E. S., Singer, M. J., Walburger, D. K., Lokhov, S. G., Gall, A. A., Dempcy, R., Reed, M. W., Meyer, R. B. & Hedgpeth, J. (2000) 3'-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res 28, 655-661.
23. Lackner, C., Cohen, J. C. & Hobbs, H. H. (1993) Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet 2, 933-940.
24. Lanktree, M. B., Anand, S. S., Yusuf, S. & Hegele, R. A., on behalf of the SHARE Investigators. (2010) Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians. Circ Cardiovasc Genet 3, 39-46.
25. Lawn, R. M., Wade, D. P., Hammer, R. E., Chiesa, G., Verstuyft, J. G. & Rubin, E. M. (1992) Atherogenesis in transgenic mice expressing human apolipoprotein(a). Nature 360, 670-672.
26. Livak, K. J. (1999) Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 14, 143-149.
27. Loscalzo, J. (1990) Lipoprotein(a): a unique risk factor for atherothrombotic disease. Arterioscler Thromb Vasc Biol 10, 672-679.
28. Lou, X. J., Boonmark, N. W., Horrigan, F. T., Degen, J. L. & Lawn, R. M. (1998) Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice. Proc Natl Acad Sci USA 95, 12591-12595.
29. Luke, M. M., Kane, J. P., Liu, D. M., Rowland, C. M., Shiffman, D., Cassano, J., Catanese, J. J., Pullinger, C. R., Leong, D. U., Arellano, A. R., Tong, C. H., Movsesyan, I., Naya-Vigne, J., Noordhof, C., Feric, N. T., Malloy, M. J., Topol, E. J., Koschinsky, M. L., Devlin, J. J. & Ellis, S. G. (2007) A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease. Arterioscler Thromb Vasc Biol 27, 2030-2036.
30. McLean, J. W., Tomlinson, J. E., Kuang, W.-J., Eaton, D. L., Chen, E. Y., Fless, G. M., Scanu, A. M. & Lawn, R. M. (1987) cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 300, 132-137.
31. Nicholls, S. J., Tang, W. H. W., Scoffone, H., Brennan, D. M., Hartiala, J., Allayee, H. & Hazen, S. L. (2010) Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy. J Lipid Res 51, 3055-3061.
32. Nordestgaard, B. G., Chapman, M. J., Ray, K., Borén, J., Andreotti, F., Watts, G. F., Ginsberg, H., Amarenco, P., Catapano, A., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., Lesnik, P., Masana, L., Reiner, Z., Taskinen, M.-R., Tokgözoglu, L. & Tybjærg-Hansen, A., for the European Atherosclerosis Society Consensus Panel. (2010) Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 31, 2844-2853.
33. Ridker, P. M., Buring, J. E., Rifai, N. & Cook, N. R. (2007) Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 297, 611-619.
34. Samani, N. J., Erdmann, J., Hall, A. S., Hengstenberg, C., Mangino, M., Mayer, B., Dixon, R. J., Meitinger, T., Braund, P., Wichmann, H.-E., Barrett, J. H., König, I. R., Stevens, S. E., Szymczak, S., Tregouet, D.-A., Iles, M. M., Pahlke, F., Pollard, H., Lieb, W., Cambien, F., Fischer, M., Ouwehand, W., Blankenberg, S., Balmforth, A. J., Baessler, A., Ball, S. G., Strom, T. M., Brænne, I., Gieger, C., Deloukas, P., Tobin, M. D., Ziegler, A., Thompson, J. R. & Schunkert, H., for the WTCCC and the Cardiogenics Consortium. (2007) Genomewide association analysis of coronary artery disease. New Engl J Med 357, 443-453.
35. Seed, M., Hoppichler, F., Reaveley, D., McCarthy, S., Thompson, G. R., Boerwinkle, E. & Utermann, G. (1990) Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 322, 1494-1499.
36. Shiffman, D., Kane, J. P., Louie, J. Z., Arellano, A. R., Ross, D. A., Catanese, J. J., Malloy, M. J., Ellis, S. G. & Devlin, J. J. (2008a) Analysis of 17, 576 potentially functional SNPs in three case-control studies of myocardial infarction. PLoS One 3, e2895.
37. Shiffman, D., O'Meara, E. S., Bare, L. A., Rowland, C. M., Louie, J. Z., Arellano, A. R., Lumley, T., Rice, K., Iakoubova, O., Luke, M. M., Young, B. A., Malloy, M. J., Kane, J. P., Ellis, S. G., Tracy, R. P., Devlin, J. J. & Psaty, B. M. (2008b) Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 28, 173-179.
38. Stephens, M., Smith, N. J. & Donnelly, P. (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68, 978-989.
39. Suk Danik, J., Rifai, N., Buring, J. E. & Ridker, P. M. (2006) Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. JAMA 296, 1363-1370.
40. Teupser, D., Rupprecht, W., Lohse, P. & Thiery, J. (2001) Fluorescence-based detection of the CETP TaqIB polymorphism: false positives with the TaqMan-based exonuclease assay attributable to a previously unknown gene variant. Clin Chem 47, 852-857.
41. The Emerging Risk Factors Collaboration. (2009) Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302, 412-423.
42. The International HapMap Consortium. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851-861.
43. Trégouët, D.-A., König, I. R., Erdmann, J., Munteanu, A., Braund, P. S., Hall, A. S., Großhennig, A., Linsel-Nitschke, P., Perret, C., DeSuremain, M., Meitinger, T., Wright, B. J., Preuss, M., Balmforth, A. J., Ball, S. G., Meisinger, C., Germain, C., Evans, A., Arveiler, D., Luc, G., Ruidavets, J.-B., Morrison, C., van der Harst, P., Schreiber, S., Neureuther, K., Schäfer, A., Bugert, P., El Mokhtari, N. E., Schrezenmeir, J., Stark, K., Rubin, D., Wichmann, H.-E., Hengstenberg, C., Ouwehand, W., Wellcome Trust Case Control Consortium, Cardiogenics Consortium, Ziegler, A., Tiret, L., Thompson, J. R., Cambien, F., Schunkert, H. & Samani, N. J. (2009) Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet 41, 283-285.
44. Tsimikas, S., Brilakis, E. S., Miller, E. R., McConnell, J. P., Lennon, R. J., Kornman, K. S., Witztum, J. L. & Berger, P. B. (2005) Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 353, 46-57.
45. World Health Organization Study Group. (1985) Diabetes mellitus. Report of a WHO study group. World Health Organ Tech Rep Ser 727, 1-113.
46. Zaykin, D. V., Westfall, P. H., Young, S. S., Karnoub, M. A., Wagner, M. J. & Ehm, M. G. (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53, 79-91.